ARCHIVES

MET Inhibitor Improved Time To Progression by 56 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

March 5, 1999

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible”

January 13, 1984